Clinical Trial Update: A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 study evaluating pazopanib tablets in patients with neovascular age-related macular degeneration. It notes the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED